GL1X · GenesisL1 explorer

Research workbench

Crystal structure of a liga inhibitor

Analyse Crystal structure of a liga inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4LH7
Type
protein
Length
321 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA ligase
EC
6.5.1.2
UniProt
Q837V6
Ligands
1X8, NMN, NA
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADNA ligase (EC 6.5.1.2)protein32142% helix, 21% strandQ837V6

Ligands and binding sites

  • 1X8 · 4-aminothieno[3,2-c]pyridine-2,7-dicarboxamide · ligand · chains A
  • NMN · Beta-nicotinamide ribose monophosphate · ligand · chains A
  • NA · Sodium ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13270.700.83471X8

Compared structures

  • 4LH7 · Crystal structure of a LigA inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q837V6 · AlphaFold monomer V2.0 prediction for DNA ligase (Q837V6) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.